All ABI Shareholders to Receive Cash and Stock in Invitrogen Merger | GenomeWeb
NEW YORK (GenomeWeb News) - Life Technologies, the new entity formed by the merger of Applied Biosystems and Invitrogen, said this week that all ABI shareholders will receive a mix of cash and Life Technologies stock, including those shareholders who elected to receive all cash, because the available cash consideration for the merger was oversubscribed.  

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.